Search Results 1871-1880 of 19627 for Hemoglobin

  1. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    Hemoglobin ≥ 8.0 g/dL;; INR or PTT/aPTT ≤ 1.5 × ULN unless participant is receiving anticoagulant therapy as long as PT or PTT is within therapeutic range ...

  2. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

    - Hemoglobin >= 8.0 g/dL (=< 15 days prior to registration) - Platelet count >= 75,000/mm^3 (=< 15 days prior to registration) - Albumin >= 2.5 g/dL (=< 15 ...

  3. A Study to Evaluate the Effectiveness of M7824 Monotherapy in Locally Advanced or Metastatic Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - Mayo Clinic

    ... hemoglobin (Hgb) ≥ 9 g/dL. Adequate hepatic function defined by a total bilirubin level ≤ 1.5 × upper limit of normal (ULN), an aspartate aminotransferase ...

  4. S1400 Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer - Mayo Clinic

    Hemoglobin >= 9 g/dL obtained within 28 days prior to sub-study registration; Serum bilirubin =< institutional upper limit of normal (IULN) within 28 days ...

  5. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

    Hemoglobin (Hgb) ≥ 9 g/dl; Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Total bilirubin ≤ 1.5 x normal institutional limits; this will ...

  6. (HARBOR) Study To Evaluate Efficacy And Safety Of BLU-263 Versus Placebo In Patients With Indolent Systemic Mastocytosis - Mayo Clinic

    Hemoglobin < 10 g/dL;; Platelet count < 100,000/µL. Hepatomegaly with ascites and impaired liver function;; Palpable splenomegaly with hypersplenism ...

  7. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL (obtained ≤ 15 days prior to registration). Absolute neutrophil count (ANC) ≥ 1500/mm^3 (obtained ≤ 15 days prior to registration) ...

  8. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  9. A Study to Assess Dendritic Cell Immunotherapy Plus Standard-of-Care to Treat Advanced Renal Cell Carcinoma - Mayo Clinic

    Hemoglobin (Hgb) 8.0 g/dL 9. Adequate renal function, as defined by either of the following criteria: 1. Serum creatinine 1.5 x upper limit of normal (ULN) ...

  10. A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR) - Mayo Clinic

    Hemoglobin (Hgb) at screening above gender-specific upper limit of normal (ULN), per local laboratory test. Baseline platelet count < 50,000/mm^3 (< 50.0 ...